Medical device PLI extended to 2035-36, rules eased
About ₹2,700 crore of the ₹3,420 crore outlay is still unspent; the Centre has dropped minimum sales thresholds and cut investment requirements to draw in more makers.
1 of 5
The Department of Pharmaceuticals has extended the medical devices PLI scheme by eight years, to 2035-36.
Nearly 80% of the ₹3,420 crore outlay is unused; about ₹2,700 crore is available for fresh applications.
Minimum sales thresholds are gone, investment norms are relaxed, and makers get three years to set up plants.